Question 1

What is PRABOTULINUM TOXIN TYPE A used for?

Accepted Answer

PRABOTULINUM TOXIN TYPE A (brand name Jeuveau) is a Other indicated for See full prescribing information.

Question 2

How does PRABOTULINUM TOXIN TYPE A work?

Accepted Answer

PRABOTULINUM TOXIN TYPE A works through the following mechanism: 12.1 Mechanism of Action JEUVEAU blocks neuromuscular transmission by binding to acceptor sites on motor nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings. When injected intramuscularly at therapeutic doses, JEUVEAU produces partial chemical denervation of the muscle resulting in a localized reduction in muscle activity. In addition, the muscle may atrophy, axonal sprouting may occur, and extrajunctional acetylcholine receptors may develop. There is evidence that reinnervation of the muscle may occur, thus slowly reversing muscle denervation produced by JEUVEAU..

Question 3

What are the most common side effects of PRABOTULINUM TOXIN TYPE A?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for PRABOTULINUM TOXIN TYPE A. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is PRABOTULINUM TOXIN TYPE A the same as Jeuveau?

Accepted Answer

Jeuveau is a brand name for PRABOTULINUM TOXIN TYPE A. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

PRABOTULINUM TOXIN TYPE A

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations